Skip to content

Relation Between Bone Density and the Regulation of Mineral Metabolism in Renal Stone Formers

Relation Between Bone Mineral Density and the Regulation of Mineral Metabolism in Renal Stone Formers

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00416052
Enrollment
90
Registered
2006-12-27
Start date
2004-03-31
Completion date
2006-06-30
Last updated
2011-05-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Calcium Nephrolithiasis

Keywords

calcium, calciuria, PTH, 1,25-vitamin D, Calcitriol, bone mineral density, osteodensitometry

Brief summary

Accumulating evidence indicated that renal calcium stone formers often exhibit a low bone density. Therefore we want to test the hypothesis, that the mineral (calcium) metabolism is differently regulated in calcium stone formers with low as opposed to high bone density.

Detailed description

There is epidemiological evidence associating renal calcium stones and decreased bone mineral density (BMD). The decreased BMD in calcium stone formers is linked to hypercalciuria and both subtypes, fasting as well as absorptive hypercalciuria are associated with a diminished BMD. Higher 1,25-vitamin D plasma concentrations and lower PTH levels are encountered under free-choice diet conditions in patients diagnosed with absorptive and fasting hypercalciuria when compared to normocalciuric stone formers. Reports studying the BMD of stone formers and its link with mineral metabolism variables and urinary calcium excretion under different calcium intakes are rare. We hypothesize now that PTH and 1,25-vitamin D change differently when calcium stone formers with high, intermediate and low BMD are challenged by a low calcium diet.

Interventions

None listed

Sponsors

Insel Gruppe AG, University Hospital Bern
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* passage of at least one calcium containing kidney stone

Exclusion criteria

* established cause of calcium stone formation (sarcoidosis, primary hyperparathyroidism etc.) * creatinine clearance \< 60 ml/min * urinary tract infection

Countries

Switzerland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026